200
Participants
Start Date
November 12, 2018
Primary Completion Date
October 25, 2021
Study Completion Date
January 19, 2022
CPI-613 + High Dose Cytarabine and Mitoxantrone
CPI-613 + High Dose Cytarabine and Mitoxantrone CPI-613: 2000mg/m2, 5 doses once a day, days 1-5 Cytarabine 1gm/m2, 5 doses every 12hrs starting day 3 through day 5 Mitoxantrone 6mg/m2, 3 doses, once a day following the first, third and fifth doses of Cytarabine
High Dose Cytarabine and Mitoxantrone
Cytarabine 1gm/m2, 5 doses every 12hrs starting day 3 through day 5 Mitoxantrone 6mg/m2, 3 doses, once a day following the first, third and fifth doses of Cytarabine
Mitoxantrone, Etoposide and Cytarabine
"Mitoxantrone, Etoposide and Cytarabine~Etoposide 80mg/m over 60 minutes as a central line IV infusion; 6 doses Day 1 though 6 Cytarabine 1000mg/m2 over 3 hours as a central line IV infusion: 6 doses, Day 1 through 6 Mitoxantrone 6 mg/m2 over 30 minutes as a central line IV infusion: 6 dose, Day 1 through 6"
Fludarabine, Cytarabine, Filgrastim
"Fludarabine, Cytarabine and Filgrastim~Fludarabine 30mg/m2/day over 30 minutes as a central line IV infusion; 5 doses Day 1 though 5 Cytarabine 2g/m2 over 4 hours as a central line IV infusion: 4 hours after Fludarabine: 5 doses, Day 1 through 5 Filgrastim 5µg/kg/day by SQ or as per institutional guidelines starting from Day 1 through Day 5"
Hanuschkrankenhaus der WGKK, Vienna
Clinique Universitaire St Luc, Brussels
Gosford Hospital, Gosford
Calvary Mater Newcastle Hospital, Waratah
Border Medical Oncology Research Unit, Albury
Paracelsus Medical University, Salzburg
Royal Perth Hospital, Perth
Algemeen Ziekenhuis Sint-Jan, Bruges
Universitätsklinik für Innere Medizin, Graz
UN Gent, Ghent
Service d'Hématologie Clinique, Hôpital Avicenne-APHP-Université Paris, Bobigny
Memorial Sloan Kettering Cancer Center, New York
Stony Brook University Hospital, Long Island City
CHU la Conecption, Marseille
CHU de Caen, Caen
University of Virginia, Charlottesville
UniversitatsklinikumUKSH Kiel, Kiel
Wake Forest Baptist Health, Winston-Salem
UNC Chapel Hill, Chapel Hill
MD Anderson Cancer Center, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
Universitatsklinikum Marburg, Marburg
Hospital Clínico Universitario de Salamanca, Salamanca
Centre Hospitalier Universitaire Grenoble Hopital Michalon, Grenoble
Norton Cancer Institute, Louisville
University of Kentucky, Lexington
Zespół Szpitali Miejskich w Chorzowie, Chorzów
Cleveland Clinic, Cleveland
University of Cincinnati, Cincinnati
Hospital U. P. La Fe, Valencia
Katedra i Klinika Hematologii, Wroclaw
University of Iowa-Holden Cancer Care Center, Iowa City
Loyola University Medical Center, Maywood
Northwestern Memorial Hospital, Chicago
University of Chicago, Chicago
Klinikum Frankfurt Hoechst, Frankfurt
Centre hospitalier Lyon Sud, Pierre-Bénite
Robert-Bosch- Krankenhaus, Stuttgart
Hopital Saint Louis, Paris
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas - Southwestern Medical Center, Dallas
Baylor Temple (BSW), Temple
MD Andrson Cancer Center, Houston
Centre Hospitalier de Versailles - Hôpital André Mignot, Le Chesnay
CHU Amiens, Amiens
Uniwersyteckie Centrum Kliniczne Klinika Hematologii i Transplantologii, Gdansk
Honor Health Research Institute, Scottsdale
Chao Family Comprehensive Cancer Center (University of California Irvine), Orange
California Pacific Medical Center, San Francisco
Oregon Health & Science University, Portland
Atlantic Health System, Morristown
Rutgers Cancer Institute of New Jersey, New Brunswick
CHU de Nice, Nice
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Institut Catala d'Oncologia (ICO) - Hospital Universitari Germans Trias i Pujol, Badalona
Hospital Vall d'Hebron, Barcelona
Hospital Son ESPASES, Palma de Mallorca
Lead Sponsor
Cornerstone Pharmaceuticals
INDUSTRY